Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q3 2025 Earnings Call Transcript November 10, 2025
Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.52316, expectations were $-0.66.
Operator: Greetings, and welcome to Mineralys Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Dan Ferry. Thank you. You may begin.
Daniel Ferry: Thank you,...
